Oxford BioMedica PLC
LSE:OXB
Oxford BioMedica PLC
LSE:OXB
Price:
632
GBX
0.32%
Market Closed
Market Cap:
£763.9m
Wall Street
Price Targets
OXB Price Targets Summary
Oxford BioMedica PLC
Oxford BioMedica PLC
Wall Street analysts forecast OXB stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
OXB
is 875.57 GBX
with a low forecast of 779.72 GBX and a high forecast of 1 018.5 GBX.
Lowest
Price Target
779.72
GBX
23% Upside
Average
Price Target
875.57
GBX
39% Upside
Highest
Price Target
1 018.5
GBX
61% Upside
Oxford BioMedica PLC Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is OXB's stock price target?
Price Target
875.57
GBX
875.57
GBX
According to Wall Street analysts, the average 1-year price target for
OXB
is 875.57 GBX
with a low forecast of 779.72 GBX and a high forecast of 1 018.5 GBX.
What is Oxford BioMedica PLC's Revenue forecast?
Projected CAGR
26%
26%
For the last 13 years the
compound annual growth rate for
Oxford BioMedica PLC's revenue is
24%.
The projected
CAGR
for the next 4 years is
26%.
